Two molecular control factors play a decisive role in what is known as splicing, the cutting and assembly of mature messenger ...

Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and development in its ...

Avidity Biosciences, Inc.'s innovative AOC platform and promising clinical programs make it a high-risk, high-reward ...

EVM14 received U.S. FDA clearance for its IND application, becoming Everest's first internally discovered program, and the first mRNA therapeutic cancer vaccine to be cleared for global clinical ...

The research field of 'cellular IRESes' lay dormant for decades, as there was no uniform standard of reliable methods for the clear characterization of these starting points for the ribosome-mediated ...

The United States has undergone several changes in foreign and domestic policy since US President Donald Trump took office in January. Scientists who rely on federal grants for their work have been ...

A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.

Siegfried Musser, PhD, and his team in the Department of Cell Biology and Genetics at the Texas A&M College of Medicine have ...

Only recently has the ribosome—one of the oldest molecular machines in evolutionary terms—been recognized as an active ...

A research team led by Yang Gao from Rice University has made significant strides in understanding the molecular mechanisms ...

A research team has uncovered new insights into the molecular mechanisms of ADAR1, a protein that regulates ribonucleic acid (RNA) induced immune responses. Their findings could open new pathways for ...